New meta-analysis reviews safety and efficacy of Epidiolex® near pure cannabidiol (CBD) in difficult to treat epilepsy
Sarah Clark2018-11-07T20:22:35+00:00New meta-analysis reviews safety and efficacy of Epidiolex® near pure cannabidiol (CBD) in difficult to treat epilepsy
Date of publication: November 3, 2018
Top line takeaways
Study design: Meta-analysis
Databases searched: Medline, the Cochrane Central Register of Controlled Trials, and clinicaltrials.gov
Number of studies included in analysis: Four
Number of patients: 550 subjects (Intention To Treat [ITT] analysis): 323 for […]